Abcalis Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
6
Abcalis General Information
Description
Developer of recombinant antibodies intended for diagnostic and research applications. The company generates and produces sequence-defined, animal-free antibodies through phage display, affinity maturation, and antibody format conversion, enabling diagnostic companies and researchers to conduct reliable tests and experiments with reproducible reagents.
Contact Information
Website
www.abcalis.comCorporate Office
- Inhoffenstrasse 7
- 38124 Braunschweig
- Germany
Corporate Office
- Inhoffenstrasse 7
- 38124 Braunschweig
- Germany
Abcalis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 5. Grant | 17-Nov-2022 | Completed | Generating Revenue | |||
| 4. Grant | 30-Mar-2022 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 22-Oct-2021 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. University Spin-Out | 01-Jan-2019 | Completed | Generating Revenue |
Abcalis Signals
Abcalis Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Braunschweigische Landessparkasse | Corporation | |||
| European Coalition to End Animal Experiments | Impact Investing | |||
| SNIC Accelerator | Accelerator/Incubator | |||
| Technische Universität Braunschweig | University | |||
| German Accelerator | Accelerator/Incubator |
Abcalis FAQs
-
When was Abcalis founded?
Abcalis was founded in 2019.
-
Where is Abcalis headquartered?
Abcalis is headquartered in Braunschweig, Germany.
-
What is the size of Abcalis?
Abcalis has 7 total employees.
-
What industry is Abcalis in?
Abcalis’s primary industry is Biotechnology.
-
Is Abcalis a private or public company?
Abcalis is a Private company.
-
What is Abcalis’s current revenue?
The current revenue for Abcalis is .
-
Who are Abcalis’s investors?
Braunschweigische Landessparkasse, European Coalition to End Animal Experiments, SNIC Accelerator, Technische Universität Braunschweig, and German Accelerator are 5 of 6 investors who have invested in Abcalis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process